BD files recast financials to reflect Feb 2026 spin-off of Biosciences & Diagnostics

BECTON DICKINSON & CO

Recast historical data presents continuing operations only, excluding the spun-off Biosciences and Diagnostic Solutions business.
Spin-off completed Feb 9, 2026, with the business combined into Waters Corporation.
Non-GAAP financial measures are included in Exhibit 99.1 to assist investor analysis.
Recast provides a baseline for BD's standalone operating results from continuing operations.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.